Free Trial

20 Stocks Wall Street Analysts Love the Most - 20 of 20

 
 

Encompass Health (NYSE:EHC)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
11 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$107.11 (8.4% Upside)

About Encompass Health

Encompass Health logoEncompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/30/2024Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$105.00 ➝ $110.00
10/30/2024Truist FinancialReiterated RatingBuy ➝ Buy$108.00 ➝ $116.00
10/29/2024BarclaysBoost Price TargetOverweight ➝ Overweight$109.00 ➝ $116.00
10/29/2024KeyCorpBoost Price TargetOverweight ➝ Overweight$115.00 ➝ $117.00
10/14/2024Truist FinancialBoost Price TargetBuy ➝ Buy$104.00 ➝ $108.00
10/11/2024KeyCorpInitiated CoverageOverweight$115.00
10/10/2024KeyCorpUpgradeStrong-Buy
9/26/2024Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$95.00 ➝ $105.00
9/25/2024UBS GroupBoost Price TargetBuy ➝ Buy$100.00 ➝ $110.00
8/15/2024Truist FinancialBoost Price TargetBuy ➝ Buy$100.00 ➝ $104.00

More Investing Slideshows:

 

Unveiled: NVIDIA’s "Secret Royalty" Program (Ad)

Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?

Click Here to learn how to get in now >>>